Max W. Talbott

406 total citations
10 papers, 325 citations indexed

About

Max W. Talbott is a scholar working on Ophthalmology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Max W. Talbott has authored 10 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 3 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Max W. Talbott's work include Intraocular Surgery and Lenses (5 papers), Ophthalmology and Visual Impairment Studies (3 papers) and Corneal surgery and disorders (3 papers). Max W. Talbott is often cited by papers focused on Intraocular Surgery and Lenses (5 papers), Ophthalmology and Visual Impairment Studies (3 papers) and Corneal surgery and disorders (3 papers). Max W. Talbott collaborates with scholars based in United States, United Kingdom and South Korea. Max W. Talbott's co-authors include David M. Worthen, Jorge N. Buxton, Robert Reinecke, Patricia E. Bath, Melvin D. Shipp, Roger W. Barnes, George Murray, Nancy E. Thomas, Daniel W. Brown and Jack T. Holladay and has published in prestigious journals such as Ophthalmology, European Journal of Pharmacology and Frontiers in Oncology.

In The Last Decade

Max W. Talbott

10 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max W. Talbott United States	7	245	151	104	32	25	10	325
Ian Yeung United Kingdom	9	240 1.0×	195 1.3×	77 0.7×	19 0.6×	15 0.6×	19	315
Samira Khan United States	9	483 2.0×	187 1.2×	20 0.2×	70 2.2×	34 1.4×	10	524
Houdijn W. Beekhuis Netherlands	10	411 1.7×	428 2.8×	153 1.5×	35 1.1×	18 0.7×	13	554
Partho S. Kalyani United States	8	297 1.2×	59 0.4×	55 0.5×	67 2.1×	51 2.0×	9	323
P. Robb McDonald United States	10	222 0.9×	92 0.6×	28 0.3×	72 2.3×	33 1.3×	26	357
Junjie Deng China	13	425 1.7×	334 2.2×	302 2.9×	50 1.6×	15 0.6×	26	559
Taichiro Miyake Japan	10	222 0.9×	145 1.0×	55 0.5×	67 2.1×	5 0.2×	17	314
Chan Yang South Korea	10	197 0.8×	193 1.3×	172 1.7×	22 0.7×	7 0.3×	24	304
Lekha Abraham India	6	220 0.9×	167 1.1×	22 0.2×	27 0.8×	22 0.9×	9	288
Petros Aristodemou United Kingdom	9	432 1.8×	371 2.5×	359 3.5×	14 0.4×	8 0.3×	14	493

Countries citing papers authored by Max W. Talbott

Since Specialization

Citations

This map shows the geographic impact of Max W. Talbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max W. Talbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max W. Talbott more than expected).

Fields of papers citing papers by Max W. Talbott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max W. Talbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max W. Talbott. The network helps show where Max W. Talbott may publish in the future.

Co-authorship network of co-authors of Max W. Talbott

This figure shows the co-authorship network connecting the top 25 collaborators of Max W. Talbott. A scholar is included among the top collaborators of Max W. Talbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max W. Talbott. Max W. Talbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Chada, Sunil, Kerstin B. Menander, Max W. Talbott, et al.. (2021). Tumor suppressor immune gene therapy to reverse immunotherapy resistance. Cancer Gene Therapy. 29(6). 825–834. 18 indexed citations

2.

Sobol, Robert E., et al.. (2021). Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 11. 645745–645745. 17 indexed citations

3.

Holladay, Jack T., Patricia E. Bath, George Murray, et al.. (1984). THE FDA REPORT ON INTRAOCULAR LENSES*. PubMed. 12(1). 61–69. 9 indexed citations

4.

Stark, Walter J., David M. Worthen, Jack T. Holladay, et al.. (1983). The FDA Report on Intraocular Lenses. Ophthalmology. 90(4). 311–317. 214 indexed citations

5.

Worthen, David M., et al.. (1981). Update Report on Intraocular Lenses. Ophthalmology. 88(5). 381–385. 9 indexed citations

6.

Worthen, David M., Jorge N. Buxton, Sohan Singh Hayreh, et al.. (1980). Interim FDA Report on Intraocular Lenses. Ophthalmology. 87(4). 267–271. 41 indexed citations

7.

Talbott, Max W.. (1979). Intraocular Lenses and the Food and Drug Administration. International Ophthalmology Clinics. 19(3). 1–10. 2 indexed citations

8.

Talbott, Max W. & Helen R. Strausser. (1977). Increase in Serum IgE Levels of Ovalbumin-Sensitized Cats and the Detection of Elastase and Collagenase Activities in Secretions of Sensitized Feline Alveolar Macrophages Challenged <i>in vitro</i>. International Archives of Allergy and Immunology. 54(3). 198–204. 5 indexed citations

9.

Talbott, Max W., et al.. (1976). Allergic bronchoconstriction and its drug-induced reversal in anesthetized, ovalbumin-sensitized cats.. PubMed. 13(4). 623–33. 7 indexed citations

10.

Talbott, Max W., et al.. (1975). A new method for evaluating antitussives in cats using an electrode-cannula. European Journal of Pharmacology. 34(1). 59–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact